Synchronous Chemoradiotherapy in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck using Capecitabine: a Single-centre, Open-label, Single-group Phase II Study-Reference-Cited by-同舟云学术

Synchronous Chemoradiotherapy in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck using Capecitabine: a Single-centre, Open-label, Single-group Phase II Study

Published:2011-03 Issue:2 Volume:23 Page:149-158
ISSN:0936-6555
Container-title:Clinical Oncology
language:en
Short-container-title:Clinical Oncology

Author:

Jegannathen A.,Mais K.,Sykes A.,Lee L.,Yap B.,Birzgalis A.,Homer J.,Ryder W.D.,Slevin N.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference47 articles.

1. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer;Pignon;Lancet,2000

2. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients;Pignon;Radiother Oncol,2009

3. Concomitant chemoradiation for head and neck cancer: saving lives or Grays?;Henk;Clin Oncol (R Coll Radiol),2001

4. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer;Adelstein;J Clin Oncol,2003

5. Preliminary results of Radiation Therapy Oncology Group 97-03: a randomized phase II trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck;Garden;J Clin Oncol,2004

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A phase I/II study evaluating the feasibility and safety of delivering adjuvant hypofractionated radiotherapy in resected oral cavity cancers (HYPO-ART study);Oral Oncology Reports;2024-06

2. Capecitabine—A “Permanent Mission” in Head and Neck Cancers “War Council”?;Journal of Clinical Medicine;2022-09-23

3. Hypofractionated Radiotherapy in Head and Neck Cancer Elderly Patients: A Feasibility and Safety Systematic Review for the Clinician;Frontiers in Oncology;2021-11-12

4. Hypofractionated chemoradiation for head and cancer: Data from the PET NECK trial;Oral Oncology;2021-02

5. Resource-sparing curative-intent hypofractionated-accelerated radiotherapy in head and neck cancer: More relevant than ever before in the COVID era;Oral Oncology;2020-12